S2-E12
N/A
Report date: 2025/04/15 11:15:33
Base Information
Drug NameS2-E12
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVir Biotechnology Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A